TristanKnightMDFRCPC(He/Him)

Pediatric Hematology & Oncology • Seattle, WA

Physician

Join to view full profile

Dr. Knight is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Knight's full profile

Already have an account?

Office
4800 Sand Point Way NE
Seattle, WA 98105
Phone+1 206-987-2000

Summary

Dr. Tristan Knight is originally from Calgary, Canada, and completed his medical training at the Royal College of Surgeons in Ireland (RCSI) in Dublin, Ireland. He then moved to Honolulu, Hawaii, for his pediatric residency, followed by a hematology/oncology fellowship in Detroit, Michigan. This was followed by a bone marrow transplant/cellular therapy fellowship at SickKids, in Toronto, Canada. In his spare time, he is an avid runner and has completed multiple marathons. He also enjoys hiking, canoeing, skiing, and diving.

Education & Training

Hospital for Sick Children (SickKids)Pediatric Bone Marrow Transplantation and Cellular Therapy, 2019 - 2021
Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 2016 - 2019
University of HawaiiResidency, Pediatrics, 2014 - 2016
University of HawaiiInternship, Pediatrics, 2013 - 2014
Royal College of Surgeons IrelandClass of 2013

Certifications & Licensure

HI State Medical License 2013 - 2026
WA State Medical License 2021 - 2026
OR State Medical License 2023 - 2025
MI State Medical License 2016 - 2023
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

14 citations
Evaluating Venetoclax and Its Potential in treatment-naïve Acute Myeloid Leukemia
Tristan Knight, Holly Edwards, Jeffrey W. Taub, Yubin Ge
Cancer Management and Research. 2019-04-23
293 citations
Prevalence of tic disorders: a systematic review and meta-analysis.
Tristan Knight, Thomas Steeves, Lundy Day, Mark Lowerison, Nathalie Jette
Pediatric Neurology. 2012-08-01
105 citations
Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-mutated Acute Myeloid Leukemia
Jun Ma, Shoujing Zhao, Xinan Qiao, Tristan Knight, Holly Edwards
Clinical Cancer Research. 2019-11-15

Lectures

The Combination of CUDC-907 and Gilteritinib Shows Promising Antileukemic Activity in Vitro and In Vivo in Preclinical Models of FLT3-ITD AML
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

External Links

LinkedInhttps://www.linkedin.com/in/tristan-knight-md-frcpc-15315a150/
Seattle Children's Hospitalhttps://www.seattlechildrens.org/directory/tristan-elliot-knight#